BIT
AERI

BlackRock Institutional Trust’s Aerie Pharmaceuticals AERI Stock Holding History

BlackRock Institutional Trust’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$30M Buy
792,213
+107,050
+16% +$4.05M ﹤0.01% 1671
2016
Q3 		$25.9M Buy
685,163
+56,319
+9% +$1.24M ﹤0.01% 1698
2016
Q2 		$11.1M Sell
628,844
-23,307
-4% -$377K ﹤0.01% 2233
2016
Q1 		$7.93M Buy
652,151
+65,298
+11% +$1.03M ﹤0.01% 2414
2015
Q4 		$14.3M Buy
586,853
+14,512
+3% +$339K ﹤0.01% 2098
2015
Q3 		$10.2M Buy
572,341
+192,360
+51% +$3.48M ﹤0.01% 2291
2015
Q2 		$6.71M Buy
379,981
+66,770
+21% +$1.22M ﹤0.01% 2631
2015
Q1 		$9.82M Buy
313,211
+127,143
+68% +$3.69M ﹤0.01% 2400
2014
Q4 		$5.43M Buy
186,068
+84,773
+84% +$2.15M ﹤0.01% 2698
2014
Q3 		$2.1M Sell
101,295
-36,784
-27% -$725K ﹤0.01% 3065
2014
Q2 		$3.42M Buy
138,079
+488
+0.4% +$8.45K ﹤0.01% 2945
2014
Q1 		$2.92M Buy
137,591
+263
+0.2% +$5.31K ﹤0.01% 3006
2013
Q4 		$2.47M Buy
+137,328
New +$1.79M ﹤0.01% 3074

Other funds holding AERI

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust's AERI Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Aerie Pharmaceuticals (AERI) stake by 16% in Q4 2016, buying an estimated $4.05M and bringing the position to 792,213 shares worth $30M. The position accounts for ﹤0.01% of the portfolio, ranked #1671.

BlackRock Institutional Trust first reported a position in AERI in Q4 2013 and has held it in 13 quarters since. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

  • BlackRock Institutional Trust held 792,213 shares of Aerie Pharmaceuticals worth $30M as of Q4 2016.
  • BlackRock Institutional Trust bought 107,050 Aerie Pharmaceuticals shares in Q4 2016, an estimated $4.05M.
  • Aerie Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1671 holding.
  • BlackRock Institutional Trust first reported a position in Aerie Pharmaceuticals in Q4 2013 and has held it in 13 quarters since.
  • 151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.